A Block Method for Pain After Back Surgery

NCT07346599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2026-01-16

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate whether bilateral lumbar erector spinae plane (ESP) block can reduce postoperative pain in adult patients undergoing lumbar spine surgery. The study also assesses the safety of this method and its effects on the recovery process. The main questions it aims to answer are:

Do patients who receive the ESP block experience less postoperative pain? Do these patients require fewer opioid (morphine-derived) analgesics? Does the first analgesic requirement occur later? Do patients mobilize earlier (stand/walk sooner)? Does the ESP block affect hemodynamic stability during and after surgery? Researchers will compare the ESP block group with the standard analgesia group to determine whether these effects occur.

Participants:

Patients in this study will be asked to:

Be randomly assigned to one of two groups before lumbar spine surgery Receive either a bilateral ESP block or standard analgesic therapy

Undergo postoperative follow-up including:

measurement of pain scores, recording of analgesic consumption, assessment of time to first analgesic requirement, monitoring of mobilization time, valuation of possible side effects

Conditions

  • Nerve Block
  • Postoperative Pain
  • Randomised Clinical Trial

Interventions

PROCEDURE

ESP block group

BILATERAL TWO-LEVEL ESP BLOCK WAS APPLIED TO PATIENTS UNDERGOING LUMBAR SPINAL SURGERY.

Sponsors & Collaborators

  • Kutahya City Hospital

    lead OTHER

Principal Investigators

  • merve kaynak · Kütahya City Hospital

  • Ali Kaynak · Kütahya City Hospital

  • bilal a bezen · Afyonkarahisar Health Sciences University Hospital

  • remziye sıvacı · Afyonkarahisar Health Sciences University Hospital

  • elif d bakı · Afyonkarahisar Health Sciences University Hospital

  • serhat yıldızhan · Afyonkarahisar Health Sciences University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-27
Primary Completion
2022-05-20
Completion
2022-05-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07346599 on ClinicalTrials.gov